These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31289348)

  • 41. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.
    Lane RF; Raines SM; Steele JW; Ehrlich ME; Lah JA; Small SA; Tanzi RE; Attie AD; Gandy S
    J Neurosci; 2010 Sep; 30(39):13110-5. PubMed ID: 20881129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.
    Tsika E; Glauser L; Moser R; Fiser A; Daniel G; Sheerin UM; Lees A; Troncoso JC; Lewis PA; Bandopadhyay R; Schneider BL; Moore DJ
    Hum Mol Genet; 2014 Sep; 23(17):4621-38. PubMed ID: 24740878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
    Lauretti E; Li JG; Di Meco A; Praticò D
    Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulation of the Retromer Complex in Brain Endothelial Cells Results in Accumulation of Phosphorylated Tau.
    Filippone A; Smith T; Pratico D
    J Inflamm Res; 2021; 14():7455-7465. PubMed ID: 35002279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
    Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.
    Domise M; Didier S; Marinangeli C; Zhao H; Chandakkar P; Buée L; Viollet B; Davies P; Marambaud P; Vingtdeux V
    Sci Rep; 2016 May; 6():26758. PubMed ID: 27230293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VPS35 regulates cell surface recycling and signaling of dopamine receptor D1.
    Wang C; Niu M; Zhou Z; Zheng X; Zhang L; Tian Y; Yu X; Bu G; Xu H; Ma Q; Zhang YW
    Neurobiol Aging; 2016 Oct; 46():22-31. PubMed ID: 27460146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.
    Wisely EV; Xiang YK; Oddo S
    Hum Mol Genet; 2014 Aug; 23(15):4024-34. PubMed ID: 24626633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
    Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
    Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice.
    Appel JR; Ye S; Tang F; Sun D; Zhang H; Mei L; Xiong WC
    J Neurosci; 2018 Jun; 38(26):5949-5968. PubMed ID: 29853629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra.
    You Y; Botros MB; Enoo AAV; Bockmiller A; Herron S; Delpech JC; Ikezu T
    Neuroscience; 2019 Dec; 422():65-74. PubMed ID: 31689387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of VPS35 in the Pathobiology of Parkinson's Disease.
    Sassone J; Reale C; Dati G; Regoni M; Pellecchia MT; Garavaglia B
    Cell Mol Neurobiol; 2021 Mar; 41(2):199-227. PubMed ID: 32323152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting tauopathy with engineered tau-degrading intrabodies.
    Gallardo G; Wong CH; Ricardez SM; Mann CN; Lin KH; Leyns CEG; Jiang H; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):38. PubMed ID: 31640765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma MicroRNAs Are Altered Early and Consistently in a Mouse Model of Tauopathy.
    Ryan B; Williams JM; Curtis MA
    Neuroscience; 2019 Jul; 411():164-176. PubMed ID: 31152932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High glucose-mediated VPS26a down-regulation dysregulates neuronal amyloid precursor protein processing and tau phosphorylation.
    Chae CW; Choi GE; Jung YH; Lim JR; Cho JH; Yoon JH; Han HJ
    Br J Pharmacol; 2022 Aug; 179(15):3934-3950. PubMed ID: 35297035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of nuclear envelope integrity as a possible initiating event in tauopathies.
    Prissette M; Fury W; Koss M; Racioppi C; Fedorova D; Dragileva E; Clarke G; Pohl T; Dugan J; Ahrens D; Chiu J; Hunt C; Siao CJ; Young T; Bhowmick A; Rogulin V; Desclaux M; Hayden EY; Podgorski M; Gao M; Macdonald LE; Frendewey D; Yancopoulos GD; Zambrowicz B
    Cell Rep; 2022 Aug; 40(8):111249. PubMed ID: 36001963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.